A spirulina supplement's secret signature: can a simple test confirm you took it?

NCT ID NCT05556967

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This pilot study tests whether specific compounds in blood or urine can serve as reliable markers that a person has consumed Immulina, a dietary supplement made from Spirulina. Healthy adults aged 18 to 50 will provide samples before and after taking the supplement to see if levels of certain fatty acids and other molecules change. The goal is to find a simple way to verify supplement intake in future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a dietary supplement called Immulina, a standardized extract from Spirulina
What this could lead to
If successful, this could provide a reliable way to confirm whether someone has taken the supplement, aiding adherence monitoring in future studies.
What could go wrong
This is a small pilot study with only 20 healthy volunteers, so results may not apply broadly. The identified biomarkers may not prove reliable in larger or more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHERENCE, PATIENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Research and Trials Unit - University of Mississippi Medical Center

    Jackson, Mississippi, 39216, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.